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METHOD AND DEVICE FOR REMOVAL OF
CRYOPROTECTANT FROM
CRYOPRESERVED BIOLOGICAL CELLS
AND TISSUES

method is suitable for cryopreserved tissue blocks, for
monolayer cell cultures, and for so-called “bioreactors”,
Wherein the cells of interest are seeded in a substantially

This application claims the bene?t of US. Provisional
Patent Application Ser. No. 60/307,989, ?led Jul. 26, 2001.

be directly passed through the semipermeable holloW ?ber

solid groWth matrix for groWth prior to immersion in the
cryoprotectant-containing liquid. It Will be appreciated that
cells in suspension in cryoprotectant-containing liquid may
membrane of the present invention. For cells groWn in or on
solid matrices, such as tissue blocks or bioreactors in a cell

This invention Was made With partial Government sup
port under NSF grant no. DMI-9901698. The Government

may have certain rights in this invention.
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TECHNICAL FIELD

cryoprotectant from suspensions of cryopreserved biological

described to remove cryoprotectant, and returned to the cell
15

biological cells and tissues folloWing thaWing.
BACKGROUND OF THE INVENTION

20

?rst ?oW rate for passing cryoprotectant-containing liquid
through the interior of the semipermeable holloW ?ber

example dimethyl sulfoxide, during cryopreservation of
cells. Use of a cryoprotectant is essential to prevent cryoin
25

cryoprotectants such as DMSO are knoWn to be toxic to

cells. Accordingly, cryoprotectant must be removed from
cryopreserved cell cultures as soon as possible after thaWing

to prevent cellular damage.

30

The most common method for removal of cryoprotectant

from cryopreserved cells is by mechanical removal, i.e.
centrifugation folloWed by resuspension in the media of

of most centrifugation processes may also result in bacterial
or viral contamination of cell preparations. Accordingly,
there is need in the art for a method of removing cryopro

35

containing liquid is provided. The method comprises the
steps of: (1) determining the membrane transfer potential of
a chosen semipermeable holloW ?ber membrane material for
a cryoprotectant of choice; (2) calculating a ?rst ?oW rate
based on the membrane transfer potential for passing the

cryoprotectant-containing liquid through the semipermeable
40

holloW ?ber membrane; (3) calculating a second ?oW rate
based on the membrane transfer potential for passing a

tectant Which does not result in cell damage or risk con

cryoprotectant-free liquid through the holloW module; (4)

tamination of cell preparations. The instant invention satis
?es this need by providing a method and device for

passing the cryoprotectant-containing liquid through at least
one semipermeable holloW ?ber membrane contained Within

removing cryoprotectant using a counter-current perfusion

Washing system.

membrane is selected to be sufficient to alloW diffusion of
the cryoprotectant from the interior of the membrane to the
exterior. The second ?oW rate for removing cryoprotectant
from the exterior surface of the membrane is selected to be
suf?cient to alloW removal of cryoprotectant from the exte
rior surface of the membrane to prevent fouling of the
exterior of the membrane ?ber.
In another aspect, a method for removing a cryoprotectant
from an interior of a cell immersed in a cryoprotectant

choice to remove the cryoprotectant by dilution. HoWever,

the mechanical forces introduced during centrifugation
result in osmotic stress and cell clumping/lysing, particu
larly if the cell of choice is fragile. The generally open nature

Any semipermeable holloW ?ber membrane capable of
alloWing passage of a cryoprotectant therethrough While
preventing passage of cells is suitable for the method of this
invention. In one presently preferred embodiment, a semi
permeable holloW ?ber membrane having a porosity of from
about 50% to about 80% is used. Typically, a semipermeable
holloW ?ber membrane having a porosity of about 70% is
used.
In accomplishing the method of the present invention, a

It is knoWn to utiliZe various cryoprotectants, such as for

jury from, e.g., formation of intracellular ice crystals during
freezing. HoWever, at room and/or body temperature, certain

media may be removed from the cell culture dish, passed
though the semipermeable holloW ?ber membranes as
culture dish.

The present invention relates to methods for removal of

cells and tissues following thaWing. The invention more
speci?cally relates to a perfusion-Washing method and
device for removal of cryoprotectant from cryopreserved

culture dish, cryoprotectant-containing liquid cell culture

45

the holloW module at the calculated ?rst ?oW rate in a ?rst
direction to contact the holloW ?ber membrane on at least

one interior surface; (5) passing the cryoprotectant-free

SUMMARY OF THE INVENTION

liquid at the second ?oW rate through the holloW module in

a second direction opposite to the ?rst direction so that the
In accordance With the purposes of the present invention
as described herein, in one aspect of the present invention a 50 cryoprotectant-free liquid contacts the semipermeable hol

method is provided for removing a cryoprotectant from an

loW ?ber on at least one exterior surface; and (5) transferring

interior of a cell immersed in a cryoprotectant-containing

cryoprotectant from the cryoprotectant-containing liquid to

liquid, comprising the steps of passing the cryoprotectant

meable holloW ?ber membrane on at least one exterior

the cryoprotectant-free liquid across a diffusion gradient
created betWeen the interior surface and the exterior surface
of the semipermeable holloW ?ber.
It Will be appreciated that the membrane transfer potential
of a particular material from Which the semipermeable
holloW ?ber is fabricated is knoWn for many suitable
materials, or may be determined by experimentation. As
noted above, the method is suitable for removing cryopro
tectant from cells any state, such as in suspension, in tissue

surface. It Will be appreciated that a diffusion gradient is

blocks, in monolayer culture, and seeded in bioreactors. The

created, thereby transferring the cryoprotectant from the
cryoprotectant-containing liquid to the cryoprotectant-free
liquid for removal.

branes and the desired ?rst and second ?oW rates are as

containing liquid through at least one semipermeable holloW
?ber membrane contained in a holloW module in a ?rst 55
direction to contact said holloW ?ber membrane on at least

one interior surface. Concurrently, a liquid Which is sub

stantially free of cryoprotectant is passed through the holloW
module in a second direction (opposite to the ?rst direction)
so that the cryoprotectant-free liquid contacts the semiper

The method of the present invention is suitable for use on

cryopreserved cells contained in suspension. Similarly, the

60

characteristics of the semipermeable holloW ?ber mem
65

described above.

In accomplishing the methods of the present invention,
the ?rst and second ?oW rate Will be calculated in accor

US 6,869,758 B1
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dance With the membrane transfer potential of the semiper
meable hollow ?ber membrane for the cryoprotectant of
choice. Thus, it Will be appreciated that the method of this
invention may be tailored speci?cally to optimal removal of

containing liquid in a ?rst direction through holloW, semi
porous membrane ?bers contained in a holloW module in
such a Way as to contact an internal surface of the ?bers.

Suitable holloW, semi-permeable ?bers and cylindrical mod

a particular cryoprotectant from a particular cell culture
media.
In yet another aspect of this invention, a device for
removing cryoprotectant from an interior of a cell immersed

ules are knoWn in the art, particularly in the dialysis arts.

in a cryoprotectant-containing liquid is provided, compris

The device 10 of the invention comprises a holloW module
20 having a ?rst inlet 22 and a ?rst outlet 24 for

Cryoprotectant-free liquid is passed through the holloW
module in a second direction, opposite to the ?rst direction,
in such a Way as to contact an external surface of the ?bers.

ing a holloW module, at least one semipermeable holloW
?ber membrane contained Within an interior of the holloW
module, a means for passing the cryoprotectant-containing

cryoprotectant-containing liquid, and a second inlet 26 and
a second outlet 28 for cryoprotectant-free liquid. As shoWn
in partial cross-section, the holloW module 20 includes a

liquid through the semipermeable holloW ?ber membrane in
a ?rst direction, and a means for passing a substantially

cryoprotectant-free liquid through the exterior holloW mod

15

ule in a second direction opposite to the ?rst direction. The

device is suitable for removing cryoprotectant from cells in
any state, such as in suspension, in tissue blocks, in mono

layer culture, and seeded in bioreactors. The characteristics
of the semipermeable holloW ?ber membranes and the

plurality of semipermeable holloW ?ber membranes 30, each
having a lumen 32. Cryoprotectant-containing liquid is
passed through inlet 22, through the lumens 32 of each
membrane 30, and out outlet 24. Concurrently,
cryoprotectant-free liquid is passed into holloW module 20
through inlet 26, through a space 34, contacting the exterior
of holloW ?ber membranes 30, and out outlet 28. Any

desired ?rst and second ?oW rates are as described above.

suitable means, such as syringe pumps or peristaltic pumps

Any suitable means may be employed for passing liquid
through the semipermeable holloW ?ber membrane and the

(not shoWn) may be used to effect ?uid ?oW through the
device of the invention.

holloW module may be used, such as a peristaltic pump, a
It Will be appreciated that, by selection of appropriate
syringe pump, or the like. The device may comprise a closed 25 holloW, semipermeable ?bers, a diffusion gradient is estab

system, Wherein cells in cryoprotectant-containing liquid are
recirculated through the semipermeable holloW ?ber mem

lished Whereby cryopreservant ?oWs from the

cryoprotectant-containing liquid (containing a relatively

brane and cryoprotectant-free liquid is recirculated through
the holloW module, or may be an open system Wherein only

high concentration of cryoprotectant) to the cryoprotectant
free liquid (containing a relatively loW concentration of

a single passage of cells/cryoprotectant-containing liquid
and cryoprotectant-free liquid are used.

cryoprotectant). When this counter-?oW perfusion technique

Other objects and applications of the present invention

containing liquid contained in the inner portion of the

Will become apparent to those skilled in this art from the

holloW ?bers into the cryoprotectant-free liquid. In a closed

folloWing description Wherein there is shoWn and described
a preferred embodiment of this invention, simply by Way of

is used, cryopreservant diffuses from the cyoprotectant

35

illustration of the modes currently best suited to carry out the
invention. As it Will be realiZed, the invention is capable of
other different embodiments and its several details are

capable of modi?cation in various, obvious aspects all
Without departing from the invention. Accordingly, the
draWings and descriptions Will be regarded as illustrative in

until the desired amount of cryopreservant is removed. It

Will be appreciated that the cryoprotectant-free liquid may
be supplied in either a closed or an open system (comprising
40

discarding cryoprotectant-free liquid after a single passage
through the holloW module).

45

In accordance With the methods of the invention, a
cylindrical module as described above Was loaded With 500
cellulose-triacetate ?bers (internal diameter 100 pm; mem

EXAMPLE 1

nature and not as restrictive.

BRIEF DESCRIPTION OF THE DRAWING

The accompanying draWing incorporated in and forming

system, the cryoprotectant-containing liquid may be recir
culated through the holloW, semipermeable membrane ?bers

a part of the speci?cation illustrates several aspects of the

brane thickness 15 pm; porosity 70%). Hematopoietic pro
genitor cells (HPCs) derived from umbilical cord blood and

present invention and, together With the description, serves
to explain the principles of the invention. In the draWing:

cryopreserved in a solution containing 10% DMSO, Were
passed through the cellulose-triacetate ?bers in a ?rst direc

FIG. 1 shoWs a schematic representation of the device of

the present invention, With the semipermeable holloW ?ber

tion. Isotonic perfusion media (substantially free of
cryoprotectant) Was passed through the cylindrical module

membranes shoWn schematically in the interior of the hol
loW module in cross-section.
FIG. 2 shoWs changes in osmolality of cord blood With

in a second direction, directly opposite to the ?rst direction,

DMSO and in cryoprotectant-free perfusion solution, and

The cell suspension Was recirculated through the ?bers by

in such a Way as to contact the outer surface of the ?bers.

percent clearance of DMSO from cord blood as a function 55 automated pumps in a closed system until over 95% of the
original concentration of DMSO Was removed.
of time of Washing.
FIG. 3 shoWs a schematic representation of the calcula
As best seen in FIG. 2, on the basis of calculated changes

tions performed by the softWare program of the present

in total osmolality, percent DMSO clearance, and change in
osmolality of the perfusion Washing medium, over 95% of

invention.

the DMSO in the cryopreserved blood sample Was removed
by the method and device of the instant invention Within 5
minutes of initiation of the Washing process. No cell clump
ing Was observed.

Reference Will noW be made in detail to a presently

preferred embodiment of the invention, examples of Which
are illustrated in the accompanying draWing.
DETAILED DESCRIPTION OF THE
INVENTION

As shoWn schematically in FIG. 1, the method of the
present invention comprises passage of a cryoprotectant

65

EXAMPLE 2
Fresh umbilical cord blood samples Were mixed With

cryoprotectant solution (20% DMSO v/v, 10% citrate

US 6,869,758 B1
5
phosphate double dextrose [CP2D] v/v, and 70% phosphate
buffered saline v/v) in a 1:1 ratio (?nal concentration of
DMSO=10% v/v). The umbilical cord blood samples Were
then cooled and cryopreserved. After 1 Week storage in
liquid nitrogen, the cells Were thaWed. Samples of the blood
Were subjected to standard centrifugation/Washing tech
niques and to the novel perfusion Washing method of the
present invention as described in Example 1 supra.
As best seen in Table 1, cell function survival Was

rap
pkrrm '41 =

1

(1)

Where Krr and KZZ are Darcy permeability in r and Z

direction respectively.
The volume average conservation of mass equation is:
16074,)

10

signi?cantly enhanced in cell preparations subjected to the
method of the present invention (compared to standard
centrifugation Washing) for removal of DMSO. FloW cytom
etry studies (not shoWn) conducted using methods knoWn in

6141 _

S

(2)

Inserting eq.(1) into eq.(2), gives:

the art shoWed that recovery of CD34+cells Was 92% for the 15

(3)

method of this invention, in comparison to 80% recovery of

CD34+cells for centrifugation Washing.
If K

TABLE 1

K22 and p are constant, eq.(3) can be simpli?ed as:

Cell function survival (%, in comparison With the fresh control) With
different cell Washing approaches (centrifugation vs. dialysis N = 8)

Centrifuge
Dialysis

CFU-E

BFU-E

CFU-GM

11.3 r 4.1%
45.0 r 3.2%

27.3 r 2.2%
47.9 r 7.3%

49.3 r 5.1%
72.5 r 4.5%

Accordingly, the method and device of the present inven
tion provides a reliable, effective means for removing cryo

Considering a ?uid control volume, Whose cross section
area is A and length is AZ. The number of holloW ?bers NH
may be estimated in this control volume by
(5)
3O

protectant from cell suspensions Which signi?cantly reduces
cell clumping, cell lysis, loss in viability, and osmotic injury.
The method is suitable for removal of cryoprotectant of
numerous useful cell types, including bone marroW/cord
blood hematopoietic progenitor cells for cancer treatment

Where AH is the cross sectional area of one holloW ?ber,

and f is packing density. Then membrane area Am in
this control volume can be determined by
35

and gene therapy, for tissue cryopreservation for

Am=NHndH-Az

(6)

transplantation, for sperm/oocyte preservation for arti?cial
Where dH is the diameter of holloW ?ber.

insemination and in vitro fertiliZation, for cryopreservation
of cell lines for research, and the like.
It Will be appreciated that the method and device of this
invention is equally suited to removal of cryoprotectant from

Therefore, Sm may be calculated by
40

(7)

cells cryopreserved other than in suspension. For example,
it is knoWn to culture and cryopreserve cells by seeding in
“bioreactors” comprising a porous groWth matrix such as

45

polyglycolic acid polymers, polylactic acid polymers,
collagen, and the like. The method of the present invention

(8)

Where Ap is the difference of pressure betWeen

cryoprotectant-containing liquid and cryoprotectant

the semipermeable holloW ?ber membranes of the invention,
and returning the media, noW free of cryoprotectant, to the

free liquid, Ac is the difference of concentration

betWeen cryoprotectant-containing liquid and
cryoprotectant-free liquid, LP is the hydraulic perme

cell culture vessel.

In still another aspect of the present invention, a method

by Kedem-Katchalsky equation (K—K equation):
JV=L[,-Ap—oL[,RT-AC

may easily be adapted for such cultures by simply extracting
the cryoprotectant-containing media bathing the porous
groWth matrix in the cell culture vessel, passing it through

for determining optimum operating conditions of the device

Where J v is the ultra?ltration rate, Which can be calculated

55

of the present invention for removal of cryoprotectant is
provided. It has been discovered that the ?rst, cell/
cryoprotectant liquid ?oW rate may be accurately predicted
using Navier-Stokes equations. FloW rate of the second,

ability of membrane, 0 is re?ection coef?cient, T is
temperature, and R is universal gas constant.
Neglecting mass transfer by shell-side diffusion or Taylor

dispersion relative to convection, the equation of concen
tration can be Written as:

cryoprotectant-free liquid may be accurately predicted using
Darcy equations. Permeating ?oW through the
semipermiable, holloW ?ber membrane for a particular cryo

protectant may be accurately predicted using Kedem

Katchalsky equations.
Darcy’s laW describes the relationship betWeen volume
average velocity and gradient of volume average pressure:

Where C is the cryoprotectant concentration, and SS is the
65

cryoprotectant source. The cryoprotectant concentra

tion in the cryoprotectantfree liquid increases from inlet
to outlet, While cryoprotectant concentration in

US 6,869,758 B1
8

7
cryoprotectant-containing liquid decreases from

the invention to the precise form disclosed. Obvious modi
?cations or variations are possible in light of the above
teachings. The embodiment Was chosen and described to
provide the best illustration of the principles of the invention
and its practical application to thereby enable one of ordi
nary skill in the art to utiliZe the invention in various

sample inlet to outlet.
SS can be estimated by

embodiments and With various modi?cations as are suited to

the particular use contemplated. All such modi?cations and
Where J5 is solute ?ux across the membrane. K—K equation

variations are Within the scope of the invention as deter

can be used to calculate J5:
10

JS=CS'(1—o)IV+PS-ACS

(10)

equitably entitled.

Where c; is average of solute concentration inside
membrane, P5 is solute diffusive permeability of mem
brane.
In a typical con?guration of the device of the present

15

invention, a bundle of semipermeable holloW ?ber mem
branes is contained in a holloW module and encapsulated at

What is claimed is:
1. A method for removing a cryoprotectant from an
interior of a cell immersed in a cryoprotectant-containing

liquid, comprising the steps of:
passing the cryoprotectant-containing liquid through at
least one semipermeable holloW ?ber membrane con
tained in a holloW module in a ?rst direction to contact
said holloW ?ber membrane on at least one interior

each end forming tubesheets. At each end, a gasket and
endcap form headers to direct sample How in and out of the
lumens of the ?bers. Accordingly, the sample How is more
uniform than cryoprotectant-free liquid ?oW. In our model,

surface;
passing a liquid Which is substantially free of cryopro
tectant through said holloW module in a second direc
tion opposite to said ?rst direction so that said

the How rate in the inlet of each ?ber membrane is assumed
to be the same. Using Navier-Stokes equations to simulate

cryoprotectant-free liquid contacts said semipermeable

the sample ?oW:

holloW ?ber membrane on at least one exterior surface;

Continuity Equation:

and

V-u=0

transferring said cryoprotectant from said cryoprotectant

(11)

containing liquid to said cryoprotectant-free liquid
across a diffusion gradient betWeen said interior surface

Momentum Equations:
1 6
14-Vu,=———p+?V2u,
P W

u-V

mined by the appended claims When interpreted in accor
dance With the breadth to Which they are fairly, legally and

p

l 6
--_p
+ 5V2

p 61

( l2)

p

( l3 ) 35

and said exterior surface of said semipermeable holloW
?ber membrane.
2. The method of claim 1, Wherein said cell is contained
in said cryoprotectant-containing liquid in a suspension.
3. The method of claim 1, Wherein said cell is a tissue

block immersed in said cryoprotectant-containing liquid.
4. The method of claim 1, Wherein said cell is seeded in
a porous groWth matrix immersed in said cryoprotectant

Concentration Equation:

containing liquid.
40

5. The method of claim 1, Wherein said cell is groWn in
a monolayer on a surface matrix immersed in said

cryoprotectant-containing liquid.

Where u is the velocity vector: u=(U,, uZ).
It Will therefore be appreciated that, using the calculations
as described above, it is possible using knoWn permeation

rates of particular cryoprotectants through speci?c semiper

6. The method of claim 2, Wherein said semipermeable
45

7. The method of claim 2, Wherein said semipermeable

meable holloW ?ber membranes to design devices in accor

dance With the present invention With optimal sample (cell

plus cryoprotectant-containing liquid) and cryoprotectant
free liquid ?oW rates for removal of cryoprotectant from the

cryoprotectant-containing liquid, and thereby from the cell
of choice. Accordingly, in yet another aspect of the present
invention, a softWare program is provided alloWing simula
tion of mass transport through the device of this invention.
The softWare predicts optimal ?oW rates for removal of

particular cryoprotectants using semipermeable holloW ?ber

holloW ?ber membrane has a porosity of from about 50% to
about 80%.

55

membranes constructed of materials of knoWn properties.
Accordingly, as shoWn in FIG. 3, the softWare program of
the present invention alloWs prediction of suitable ?oW rates
as described above for cryoprotectant removal for any
combination of cryoprotectant and holloW ?ber material.
Thus, the user is able to determine the optimal ?oW rate of

holloW ?ber membrane has a porosity of about 70%.
8. The method of claim 1, Wherein said ?rst ?oW rate is
suf?cient to alloW transfer of cryoprotectant contained in
said cryoprotectant-containing liquid from said interior sur
face of said semipermeable holloW ?ber membrane to said
exterior surface of said semipermeable holloW ?ber mem
brane.
9. The method of claim 1, Wherein said second ?oW rate
is sufficient to substantially prevent retention of cryopro
tectant on said exterior surface of said semipermeable hol
loW ?ber membrane.
10. A method for removing a cryoprotectant from an
interior of a cell immersed in a cryoprotectant-containing

liquid, comprising the steps of:

cryoprotectant-containing liquid and cryoprotectant-free liq

determining a membrane transfer potential of a semiper
meable holloW ?ber membrane for said cryoprotectant;

uid for removal of cryoprotectant in the most ef?cient

calculating a ?rst ?oW rate based on said membrane

transfer potential for passing the cryoprotectant

manner.

The foregoing description of a preferred embodiment of
the invention has been presented for purposes of illustration
and description. It is not intended to be exhaustive or to limit

65

containing liquid through said semipermeable holloW
?ber membrane to remove said cryoprotectant from

said cryoprotectant-containing liquid;

US 6,869,758 B1
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10
13. The method of claim 10, Wherein said cell is contained
in a porous groWth matrix immersed in said cryoprotectant

calculating a second ?oW rate based on said membrane

transfer potential for passing a cryoprotectant-free liq
uid through said hollow module;

containing liquid.

passing the cryoprotectant-containing liquid through at

14. The method of claim 10, Wherein said cell is groWn in
monolayer culture on a solid matrix prior to immersion in

least one said semipermeable holloW ?ber membrane
contained Within the holloW module at said ?rst ?oW

said cryoprotectant-containing liquid.

rate in a ?rst direction to contact said holloW ?ber
membrane on at least one interior surface;

15. The method of claim 10, Wherein said porous holloW
?ber membrane has a porosity of from about 50% to about

passing the cryoprotectant-free liquid at said second ?oW
rate through the holloW module in a second direction
opposite to said ?rst direction so that said

10

cryoprotectant-free liquid contacts said semipermeable
holloW ?ber on at least one exterior surface; and

transferring said cryoprotectant from said cryoprotectant

containing liquid to said cryoprotectant-free liquid
across a diffusion gradient created betWeen said interior

surface and said exterior surface of said semipermeable
holloW ?ber.
11. The method of claim 10, Wherein said cell is contained

in said cryoprotectant-containing liquid in suspension.
12. The method of claim 10, Wherein said cell is contained
in a tissue block immersed in said cryoprotectant-containing

liquid.

15

80%.
16. The method of claim 10, Wherein said porous holloW
?ber membrane has a porosity of about 70%.
17. The method of claim 1, Wherein said ?rst ?oW rate is
suf?cient to alloW transfer of cryoprotectant contained in
said cryoprotectant-containing liquid from said interior sur
face of said semipermeable holloW ?ber membrane to said
exterior surface of said semipermeable holloW ?ber mem
brane.
18. The method of claim 1, Wherein said second ?oW rate
is sufficient to substantially prevent retention of cryopro
tectant on said exterior surface of said semipermeable hol
loW ?ber membrane.

